SINCEREWATCH HK(00444.HK)延長承兑票據到期日
格隆匯4月29日丨SINCEREWATCH HK(00444.HK)宣佈,於2018年2月12日,公司、賣方聯冠投資及擔保人崔濤訂立協議,據此,公司向賣方收購目標公司聯冠發展全部已發行股本,代價為3.5億港元。該代價將以配發及發行代價股份(支付其中1.2億港元)、發行承兑票據(支付其中1.5億港元),以及現金支付的形式進行。
公司及承兑票據持有人均同意將承兑票據的到期日由2020年4月30日延長至2020年8月31日。承兑票據的所有其他條款將維持有效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.